PRESS RELEASES

GENERAL

Chinese Pharma Licenses Two Drugs

A Chinese pharmaceutical company is licensing two experimental drugs from two University of Texas research institutions for an initial $4.5 million upfront payment.

read more

ALMB-0166

ALMB-0168

FOR INVESTMENT BUSINESS
OPPORTUNITY

AlaMab would welcome the opportunity to discuss possible investment or partnering opportunities.